Consensus Vanda Pharmaceuticals Inc.

Equities

VNDA

US9216591084

Real-time Estimate Cboe BZX 03:24:30 2024-03-28 pm EDT 5-day change 1st Jan Change
4.165 USD +7.07% Intraday chart for Vanda Pharmaceuticals Inc. +6.91% -0.95%

Evolution of the average Target Price on Vanda Pharmaceuticals Inc.

Price target over the last 5 years

History of analyst recommendation changes

3bd8dc86fb988339fbf22410796.-miySBVcSMJAIqudyY1b2TOgXg01wTbZh_mI7D8KGRc.kxvRelINOINzZ83y8dIZigrwDW9qqFC9yJ76lHZkLWaWOtkdIS9loB91mw~2ffe898de3074d8bfe2a5ad277151dbd

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
3.89 USD
Average target price
4.25 USD
Spread / Average Target
+9.25%
High Price Target
4.25 USD
Spread / Highest target
+9.25%
Low Price Target
4.25 USD
Spread / Lowest Target
+9.25%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Vanda Pharmaceuticals Inc.

Jefferies & Co.
BofA Securities
Citigroup
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings